Cryo-Cell International Statistics
Share Statistics
Cryo-Cell International has 8.08M
shares outstanding. The number of shares has increased by -0.28%
in one year.
| Shares Outstanding | 8.08M |
| Shares Change (YoY) | -0.28% |
| Shares Change (QoQ) | 0.25% |
| Owned by Institutions (%) | 12.79% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 2 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 3.73K, so 0.05% of the outstanding
shares have been sold short.
| Short Interest | 3.73K |
| Short % of Shares Out | 0.05% |
| Short % of Float | 0.07% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is 175.31 and the forward
PE ratio is -122.16.
Cryo-Cell International's PEG ratio is
-1.68.
| PE Ratio | 175.31 |
| Forward PE | -122.16 |
| PS Ratio | 2.2 |
| Forward PS | 1.2 |
| PB Ratio | -5.33 |
| P/FCF Ratio | 19.54 |
| PEG Ratio | -1.68 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Cryo-Cell International.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.58,
with a Debt / Equity ratio of -0.98.
| Current Ratio | 0.58 |
| Quick Ratio | 0.55 |
| Debt / Equity | -0.98 |
| Debt / EBITDA | 9.09 |
| Debt / FCF | 3.59 |
| Interest Coverage | 1.87 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $390,074.46 |
| Profits Per Employee | $4,903.6 |
| Employee Count | 82 |
| Asset Turnover | 0.49 |
| Inventory Turnover | 12.08 |
Taxes
| Income Tax | 2.4M |
| Effective Tax Rate | 85.66% |
Stock Price Statistics
The stock price has increased by -47.48% in the
last 52 weeks. The beta is 0.81, so Cryo-Cell International's
price volatility has been higher than the market average.
| Beta | 0.81 |
| 52-Week Price Change | -47.48% |
| 50-Day Moving Average | 5.65 |
| 200-Day Moving Average | 6.87 |
| Relative Strength Index (RSI) | 36.73 |
| Average Volume (20 Days) | 13,200 |
Income Statement
In the last 12 months, Cryo-Cell International had revenue of 31.99M
and earned 402.1K
in profits. Earnings per share was 0.05.
| Revenue | 31.99M |
| Gross Profit | 24.04M |
| Operating Income | 3.48M |
| Net Income | 402.1K |
| EBITDA | 1.42M |
| EBIT | 939.44K |
| Earnings Per Share (EPS) | 0.05 |
Full Income StatementBalance Sheet
The company has 560.96K in cash and 12.93M in
debt, giving a net cash position of -12.37M.
| Cash & Cash Equivalents | 560.96K |
| Total Debt | 12.93M |
| Net Cash | -12.37M |
| Retained Earnings | -32.78M |
| Total Assets | 64.38M |
| Working Capital | -9.21M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 6.01M
and capital expenditures -2.4M, giving a free cash flow of 3.61M.
| Operating Cash Flow | 6.01M |
| Capital Expenditures | -2.4M |
| Free Cash Flow | 3.61M |
| FCF Per Share | 0.44 |
Full Cash Flow StatementMargins
Gross margin is 75.15%, with operating and profit margins of 10.88% and 1.26%.
| Gross Margin | 75.15% |
| Operating Margin | 10.88% |
| Pretax Margin | 8.77% |
| Profit Margin | 1.26% |
| EBITDA Margin | 4.45% |
| EBIT Margin | 10.88% |
| FCF Margin | 11.28% |
